nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP2C19—Vismodegib—skin cancer	0.0703	0.15	CbGbCtD
Quetiapine—ABCB1—Vismodegib—skin cancer	0.0567	0.121	CbGbCtD
Quetiapine—CYP3A4—Imiquimod—skin cancer	0.049	0.105	CbGbCtD
Quetiapine—CYP3A4—Temozolomide—skin cancer	0.049	0.105	CbGbCtD
Quetiapine—CYP2D6—Vemurafenib—skin cancer	0.0422	0.09	CbGbCtD
Quetiapine—CYP3A4—Vismodegib—skin cancer	0.034	0.0724	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0315	0.0672	CbGbCtD
Quetiapine—CYP3A7—Docetaxel—skin cancer	0.0315	0.0672	CbGbCtD
Quetiapine—ABCB1—Dactinomycin—skin cancer	0.0298	0.0635	CbGbCtD
Quetiapine—CYP3A4—Vemurafenib—skin cancer	0.0269	0.0573	CbGbCtD
Quetiapine—CYP3A5—Docetaxel—skin cancer	0.0236	0.0504	CbGbCtD
Quetiapine—DRD5—eyelid—skin cancer	0.017	0.136	CbGeAlD
Quetiapine—ABCB1—Docetaxel—skin cancer	0.0154	0.0328	CbGbCtD
Quetiapine—CYP3A4—Docetaxel—skin cancer	0.00922	0.0196	CbGbCtD
Quetiapine—CHRM3—muscle of abdomen—skin cancer	0.00728	0.0586	CbGeAlD
Quetiapine—HRH1—nose—skin cancer	0.00563	0.0452	CbGeAlD
Quetiapine—CHRM5—skin epidermis—skin cancer	0.00476	0.0383	CbGeAlD
Quetiapine—DRD1—nerve—skin cancer	0.00346	0.0278	CbGeAlD
Quetiapine—HTR3A—nerve—skin cancer	0.00334	0.0268	CbGeAlD
Quetiapine—H1F0—hair follicle—skin cancer	0.00293	0.0236	CbGeAlD
Quetiapine—HTR2A—hindlimb—skin cancer	0.00221	0.0178	CbGeAlD
Quetiapine—HTR1B—blood vessel—skin cancer	0.0022	0.0177	CbGeAlD
Quetiapine—HTR7—nerve—skin cancer	0.00216	0.0174	CbGeAlD
Quetiapine—HTR1D—blood vessel—skin cancer	0.00213	0.0171	CbGeAlD
Quetiapine—DRD2—nerve—skin cancer	0.00204	0.0164	CbGeAlD
Quetiapine—H1F0—nipple—skin cancer	0.00199	0.016	CbGeAlD
Quetiapine—H1F0—neck—skin cancer	0.00197	0.0158	CbGeAlD
Quetiapine—HTR2A—appendage—skin cancer	0.0019	0.0153	CbGeAlD
Quetiapine—HTR7—endothelium—skin cancer	0.00184	0.0148	CbGeAlD
Quetiapine—HTR7—blood vessel—skin cancer	0.0017	0.0136	CbGeAlD
Quetiapine—CHRM5—epithelium—skin cancer	0.00155	0.0125	CbGeAlD
Quetiapine—CHRM5—skin of body—skin cancer	0.00148	0.0119	CbGeAlD
Quetiapine—H1F0—connective tissue—skin cancer	0.00141	0.0113	CbGeAlD
Quetiapine—HTR1E—head—skin cancer	0.0014	0.0113	CbGeAlD
Quetiapine—ADRA1D—epithelium—skin cancer	0.00139	0.0111	CbGeAlD
Quetiapine—HTR2A—nerve—skin cancer	0.00135	0.0108	CbGeAlD
Quetiapine—DRD5—lymphoid tissue—skin cancer	0.00133	0.0107	CbGeAlD
Quetiapine—DRD5—female reproductive system—skin cancer	0.00128	0.0103	CbGeAlD
Quetiapine—H1F0—skin of body—skin cancer	0.00127	0.0102	CbGeAlD
Quetiapine—CHRM4—head—skin cancer	0.00123	0.0099	CbGeAlD
Quetiapine—HTR7—neck—skin cancer	0.00121	0.00975	CbGeAlD
Quetiapine—H1F0—mammalian vulva—skin cancer	0.00116	0.00933	CbGeAlD
Quetiapine—HTR2A—endothelium—skin cancer	0.00115	0.00922	CbGeAlD
Quetiapine—DRD3—head—skin cancer	0.00114	0.0092	CbGeAlD
Quetiapine—ADRA2C—nipple—skin cancer	0.00113	0.00906	CbGeAlD
Quetiapine—HTR6—head—skin cancer	0.0011	0.00886	CbGeAlD
Quetiapine—HTR1D—connective tissue—skin cancer	0.00109	0.00877	CbGeAlD
Quetiapine—DRD5—head—skin cancer	0.00107	0.00862	CbGeAlD
Quetiapine—HTR2A—blood vessel—skin cancer	0.00106	0.0085	CbGeAlD
Quetiapine—H1F0—lymphoid tissue—skin cancer	0.00103	0.00828	CbGeAlD
Quetiapine—ADRA1D—female reproductive system—skin cancer	0.00103	0.00828	CbGeAlD
Quetiapine—H1F0—female reproductive system—skin cancer	0.000994	0.00799	CbGeAlD
Quetiapine—CHRM5—head—skin cancer	0.000963	0.00774	CbGeAlD
Quetiapine—HRH1—nipple—skin cancer	0.000915	0.00736	CbGeAlD
Quetiapine—ADRA2A—nipple—skin cancer	0.000899	0.00723	CbGeAlD
Quetiapine—ADRA1B—head—skin cancer	0.000879	0.00707	CbGeAlD
Quetiapine—HTR7—connective tissue—skin cancer	0.000869	0.00699	CbGeAlD
Quetiapine—ADRA1D—head—skin cancer	0.00086	0.00692	CbGeAlD
Quetiapine—H1F0—head—skin cancer	0.00083	0.00667	CbGeAlD
Quetiapine—HTR7—epithelium—skin cancer	0.000825	0.00663	CbGeAlD
Quetiapine—DRD1—head—skin cancer	0.00082	0.00659	CbGeAlD
Quetiapine—ADRA1A—epithelium—skin cancer	0.000796	0.0064	CbGeAlD
Quetiapine—HTR1B—female reproductive system—skin cancer	0.000795	0.00639	CbGeAlD
Quetiapine—HTR3A—head—skin cancer	0.000792	0.00636	CbGeAlD
Quetiapine—HTR1D—female reproductive system—skin cancer	0.00077	0.00619	CbGeAlD
Quetiapine—HTR2C—female reproductive system—skin cancer	0.000762	0.00613	CbGeAlD
Quetiapine—HTR2A—neck—skin cancer	0.000756	0.00608	CbGeAlD
Quetiapine—CHRM1—female reproductive system—skin cancer	0.00072	0.00579	CbGeAlD
Quetiapine—ABCB1—blood vessel—skin cancer	0.000693	0.00557	CbGeAlD
Quetiapine—HTR1B—head—skin cancer	0.000664	0.00534	CbGeAlD
Quetiapine—CHRM2—head—skin cancer	0.000661	0.00531	CbGeAlD
Quetiapine—ADRA2C—mammalian vulva—skin cancer	0.000658	0.00529	CbGeAlD
Quetiapine—HRH1—connective tissue—skin cancer	0.000649	0.00522	CbGeAlD
Quetiapine—CHRM3—female reproductive system—skin cancer	0.000644	0.00518	CbGeAlD
Quetiapine—HTR1D—head—skin cancer	0.000643	0.00517	CbGeAlD
Quetiapine—ADRA2A—connective tissue—skin cancer	0.000638	0.00513	CbGeAlD
Quetiapine—HTR2C—head—skin cancer	0.000637	0.00512	CbGeAlD
Quetiapine—HRH1—epithelium—skin cancer	0.000616	0.00495	CbGeAlD
Quetiapine—ADRA1A—lymphoid tissue—skin cancer	0.000613	0.00493	CbGeAlD
Quetiapine—HTR7—female reproductive system—skin cancer	0.000613	0.00493	CbGeAlD
Quetiapine—CHRM1—head—skin cancer	0.000601	0.00483	CbGeAlD
Quetiapine—H1F0—lymph node—skin cancer	0.000581	0.00467	CbGeAlD
Quetiapine—HTR2A—connective tissue—skin cancer	0.000542	0.00436	CbGeAlD
Quetiapine—CHRM3—head—skin cancer	0.000538	0.00433	CbGeAlD
Quetiapine—HTR1A—head—skin cancer	0.000536	0.00431	CbGeAlD
Quetiapine—HRH1—mammalian vulva—skin cancer	0.000535	0.0043	CbGeAlD
Quetiapine—ADRA2A—mammalian vulva—skin cancer	0.000525	0.00422	CbGeAlD
Quetiapine—HTR2A—epithelium—skin cancer	0.000515	0.00414	CbGeAlD
Quetiapine—HTR7—head—skin cancer	0.000512	0.00412	CbGeAlD
Quetiapine—ADRA1A—head—skin cancer	0.000494	0.00397	CbGeAlD
Quetiapine—DRD2—head—skin cancer	0.000484	0.00389	CbGeAlD
Quetiapine—ADRA2C—head—skin cancer	0.000471	0.00378	CbGeAlD
Quetiapine—HRH1—female reproductive system—skin cancer	0.000458	0.00368	CbGeAlD
Quetiapine—ADRA2A—female reproductive system—skin cancer	0.00045	0.00361	CbGeAlD
Quetiapine—HRH1—head—skin cancer	0.000382	0.00307	CbGeAlD
Quetiapine—HTR2A—female reproductive system—skin cancer	0.000382	0.00307	CbGeAlD
Quetiapine—ADRA2A—head—skin cancer	0.000376	0.00302	CbGeAlD
Quetiapine—CYP3A4—female reproductive system—skin cancer	0.000354	0.00285	CbGeAlD
Quetiapine—CYP2D6—female reproductive system—skin cancer	0.000348	0.0028	CbGeAlD
Quetiapine—ABCB1—epithelium—skin cancer	0.000337	0.00271	CbGeAlD
Quetiapine—ADRA2C—lymph node—skin cancer	0.00033	0.00265	CbGeAlD
Quetiapine—Cough—Bleomycin—skin cancer	0.000329	0.000982	CcSEcCtD
Quetiapine—Chills—Temozolomide—skin cancer	0.000327	0.000978	CcSEcCtD
Quetiapine—Dehydration—Docetaxel—skin cancer	0.000326	0.000974	CcSEcCtD
Quetiapine—Ill-defined disorder—Dactinomycin—skin cancer	0.000326	0.000973	CcSEcCtD
Quetiapine—Anaemia—Dactinomycin—skin cancer	0.000325	0.00097	CcSEcCtD
Quetiapine—Vomiting—Vemurafenib—skin cancer	0.000323	0.000963	CcSEcCtD
Quetiapine—Dry skin—Docetaxel—skin cancer	0.000322	0.00096	CcSEcCtD
Quetiapine—Chest pain—Bleomycin—skin cancer	0.000321	0.000958	CcSEcCtD
Quetiapine—Myalgia—Bleomycin—skin cancer	0.000321	0.000958	CcSEcCtD
Quetiapine—Abdominal pain upper—Docetaxel—skin cancer	0.00032	0.000957	CcSEcCtD
Quetiapine—Orthostatic hypotension—Docetaxel—skin cancer	0.00032	0.000957	CcSEcCtD
Quetiapine—Rash—Vemurafenib—skin cancer	0.00032	0.000955	CcSEcCtD
Quetiapine—Mental disorder—Temozolomide—skin cancer	0.00032	0.000955	CcSEcCtD
Quetiapine—Dermatitis—Vemurafenib—skin cancer	0.00032	0.000955	CcSEcCtD
Quetiapine—HTR2A—head—skin cancer	0.000319	0.00257	CbGeAlD
Quetiapine—Hypersensitivity—Imiquimod—skin cancer	0.000319	0.000952	CcSEcCtD
Quetiapine—Headache—Vemurafenib—skin cancer	0.000318	0.000949	CcSEcCtD
Quetiapine—Malnutrition—Temozolomide—skin cancer	0.000318	0.000949	CcSEcCtD
Quetiapine—Breast disorder—Docetaxel—skin cancer	0.000317	0.000947	CcSEcCtD
Quetiapine—Discomfort—Bleomycin—skin cancer	0.000317	0.000946	CcSEcCtD
Quetiapine—Malaise—Dactinomycin—skin cancer	0.000317	0.000946	CcSEcCtD
Quetiapine—Cramp muscle—Docetaxel—skin cancer	0.000316	0.000944	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000316	0.000944	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000316	0.000944	CcSEcCtD
Quetiapine—Leukopenia—Dactinomycin—skin cancer	0.000314	0.000939	CcSEcCtD
Quetiapine—Nasopharyngitis—Docetaxel—skin cancer	0.000314	0.000937	CcSEcCtD
Quetiapine—Dysgeusia—Temozolomide—skin cancer	0.000311	0.000929	CcSEcCtD
Quetiapine—Asthenia—Imiquimod—skin cancer	0.00031	0.000927	CcSEcCtD
Quetiapine—Confusional state—Bleomycin—skin cancer	0.00031	0.000926	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000309	0.000924	CcSEcCtD
Quetiapine—Anaphylactic shock—Bleomycin—skin cancer	0.000307	0.000918	CcSEcCtD
Quetiapine—Back pain—Temozolomide—skin cancer	0.000307	0.000918	CcSEcCtD
Quetiapine—Pruritus—Imiquimod—skin cancer	0.000306	0.000914	CcSEcCtD
Quetiapine—Infection—Bleomycin—skin cancer	0.000305	0.000912	CcSEcCtD
Quetiapine—Dysphagia—Docetaxel—skin cancer	0.000303	0.000906	CcSEcCtD
Quetiapine—Nausea—Vemurafenib—skin cancer	0.000301	0.0009	CcSEcCtD
Quetiapine—Thrombocytopenia—Bleomycin—skin cancer	0.000301	0.000899	CcSEcCtD
Quetiapine—Vision blurred—Temozolomide—skin cancer	0.000299	0.000894	CcSEcCtD
Quetiapine—Myalgia—Dactinomycin—skin cancer	0.000299	0.000893	CcSEcCtD
Quetiapine—Tremor—Temozolomide—skin cancer	0.000298	0.000889	CcSEcCtD
Quetiapine—Diarrhoea—Imiquimod—skin cancer	0.000296	0.000884	CcSEcCtD
Quetiapine—Discomfort—Dactinomycin—skin cancer	0.000295	0.000882	CcSEcCtD
Quetiapine—Angina pectoris—Docetaxel—skin cancer	0.000295	0.000882	CcSEcCtD
Quetiapine—Ill-defined disorder—Temozolomide—skin cancer	0.000295	0.00088	CcSEcCtD
Quetiapine—Anaemia—Temozolomide—skin cancer	0.000294	0.000877	CcSEcCtD
Quetiapine—Anorexia—Bleomycin—skin cancer	0.000293	0.000875	CcSEcCtD
Quetiapine—ABCB1—mammalian vulva—skin cancer	0.000293	0.00235	CbGeAlD
Quetiapine—Agitation—Temozolomide—skin cancer	0.000292	0.000872	CcSEcCtD
Quetiapine—CYP2D6—head—skin cancer	0.000291	0.00234	CbGeAlD
Quetiapine—Angioedema—Temozolomide—skin cancer	0.00029	0.000867	CcSEcCtD
Quetiapine—Hypotension—Bleomycin—skin cancer	0.000287	0.000858	CcSEcCtD
Quetiapine—Malaise—Temozolomide—skin cancer	0.000287	0.000856	CcSEcCtD
Quetiapine—Dizziness—Imiquimod—skin cancer	0.000286	0.000855	CcSEcCtD
Quetiapine—Vertigo—Temozolomide—skin cancer	0.000285	0.000853	CcSEcCtD
Quetiapine—Infection—Dactinomycin—skin cancer	0.000285	0.000851	CcSEcCtD
Quetiapine—Leukopenia—Temozolomide—skin cancer	0.000284	0.000849	CcSEcCtD
Quetiapine—Neutropenia—Docetaxel—skin cancer	0.000284	0.000847	CcSEcCtD
Quetiapine—Palpitations—Temozolomide—skin cancer	0.000281	0.000839	CcSEcCtD
Quetiapine—Thrombocytopenia—Dactinomycin—skin cancer	0.000281	0.000838	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00028	0.000836	CcSEcCtD
Quetiapine—Cough—Temozolomide—skin cancer	0.000277	0.000828	CcSEcCtD
Quetiapine—Paraesthesia—Bleomycin—skin cancer	0.000276	0.000824	CcSEcCtD
Quetiapine—Weight increased—Docetaxel—skin cancer	0.000276	0.000824	CcSEcCtD
Quetiapine—Vision blurred—Fluorouracil—skin cancer	0.000276	0.000824	CcSEcCtD
Quetiapine—Convulsion—Temozolomide—skin cancer	0.000275	0.000822	CcSEcCtD
Quetiapine—Vomiting—Imiquimod—skin cancer	0.000275	0.000822	CcSEcCtD
Quetiapine—Weight decreased—Docetaxel—skin cancer	0.000274	0.000819	CcSEcCtD
Quetiapine—Hypertension—Temozolomide—skin cancer	0.000274	0.000819	CcSEcCtD
Quetiapine—Dyspnoea—Bleomycin—skin cancer	0.000274	0.000819	CcSEcCtD
Quetiapine—Anorexia—Dactinomycin—skin cancer	0.000273	0.000816	CcSEcCtD
Quetiapine—Rash—Imiquimod—skin cancer	0.000273	0.000815	CcSEcCtD
Quetiapine—Dermatitis—Imiquimod—skin cancer	0.000273	0.000814	CcSEcCtD
Quetiapine—Pneumonia—Docetaxel—skin cancer	0.000272	0.000812	CcSEcCtD
Quetiapine—Headache—Imiquimod—skin cancer	0.000271	0.00081	CcSEcCtD
Quetiapine—Anaemia—Fluorouracil—skin cancer	0.000271	0.000808	CcSEcCtD
Quetiapine—Arthralgia—Temozolomide—skin cancer	0.00027	0.000808	CcSEcCtD
Quetiapine—Myalgia—Temozolomide—skin cancer	0.00027	0.000808	CcSEcCtD
Quetiapine—Infestation NOS—Docetaxel—skin cancer	0.00027	0.000808	CcSEcCtD
Quetiapine—Infestation—Docetaxel—skin cancer	0.00027	0.000808	CcSEcCtD
Quetiapine—Anxiety—Temozolomide—skin cancer	0.00027	0.000805	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000269	0.000802	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000268	0.000801	CcSEcCtD
Quetiapine—HRH1—lymph node—skin cancer	0.000268	0.00215	CbGeAlD
Quetiapine—Discomfort—Temozolomide—skin cancer	0.000267	0.000798	CcSEcCtD
Quetiapine—Decreased appetite—Bleomycin—skin cancer	0.000267	0.000798	CcSEcCtD
Quetiapine—Dry mouth—Temozolomide—skin cancer	0.000265	0.00079	CcSEcCtD
Quetiapine—Stomatitis—Docetaxel—skin cancer	0.000264	0.000787	CcSEcCtD
Quetiapine—Jaundice—Docetaxel—skin cancer	0.000264	0.000787	CcSEcCtD
Quetiapine—ADRA2A—lymph node—skin cancer	0.000263	0.00211	CbGeAlD
Quetiapine—Pain—Bleomycin—skin cancer	0.000263	0.000785	CcSEcCtD
Quetiapine—Conjunctivitis—Docetaxel—skin cancer	0.000263	0.000785	CcSEcCtD
Quetiapine—Leukopenia—Fluorouracil—skin cancer	0.000262	0.000783	CcSEcCtD
Quetiapine—Confusional state—Temozolomide—skin cancer	0.000261	0.000781	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000261	0.00078	CcSEcCtD
Quetiapine—ABCB1—lymphoid tissue—skin cancer	0.00026	0.00209	CbGeAlD
Quetiapine—Anaphylactic shock—Temozolomide—skin cancer	0.000259	0.000774	CcSEcCtD
Quetiapine—Infection—Temozolomide—skin cancer	0.000258	0.000769	CcSEcCtD
Quetiapine—Nausea—Imiquimod—skin cancer	0.000257	0.000768	CcSEcCtD
Quetiapine—Hepatobiliary disease—Docetaxel—skin cancer	0.000256	0.000764	CcSEcCtD
Quetiapine—Epistaxis—Docetaxel—skin cancer	0.000255	0.000762	CcSEcCtD
Quetiapine—Nervous system disorder—Temozolomide—skin cancer	0.000254	0.000759	CcSEcCtD
Quetiapine—Thrombocytopenia—Temozolomide—skin cancer	0.000254	0.000758	CcSEcCtD
Quetiapine—Convulsion—Fluorouracil—skin cancer	0.000254	0.000758	CcSEcCtD
Quetiapine—Feeling abnormal—Bleomycin—skin cancer	0.000253	0.000757	CcSEcCtD
Quetiapine—Agranulocytosis—Docetaxel—skin cancer	0.000252	0.000754	CcSEcCtD
Quetiapine—Skin disorder—Temozolomide—skin cancer	0.000252	0.000752	CcSEcCtD
Quetiapine—Hyperhidrosis—Temozolomide—skin cancer	0.000251	0.000749	CcSEcCtD
Quetiapine—ABCB1—female reproductive system—skin cancer	0.000251	0.00201	CbGeAlD
Quetiapine—Chest pain—Fluorouracil—skin cancer	0.000249	0.000744	CcSEcCtD
Quetiapine—Myalgia—Fluorouracil—skin cancer	0.000249	0.000744	CcSEcCtD
Quetiapine—Decreased appetite—Dactinomycin—skin cancer	0.000249	0.000744	CcSEcCtD
Quetiapine—Fatigue—Dactinomycin—skin cancer	0.000247	0.000738	CcSEcCtD
Quetiapine—Anorexia—Temozolomide—skin cancer	0.000247	0.000738	CcSEcCtD
Quetiapine—Discomfort—Fluorouracil—skin cancer	0.000246	0.000735	CcSEcCtD
Quetiapine—Pain—Dactinomycin—skin cancer	0.000245	0.000732	CcSEcCtD
Quetiapine—Haemoglobin—Docetaxel—skin cancer	0.000244	0.000729	CcSEcCtD
Quetiapine—Rhinitis—Docetaxel—skin cancer	0.000243	0.000727	CcSEcCtD
Quetiapine—Body temperature increased—Bleomycin—skin cancer	0.000243	0.000726	CcSEcCtD
Quetiapine—Hepatitis—Docetaxel—skin cancer	0.000243	0.000725	CcSEcCtD
Quetiapine—Haemorrhage—Docetaxel—skin cancer	0.000243	0.000725	CcSEcCtD
Quetiapine—Hypoaesthesia—Docetaxel—skin cancer	0.000242	0.000721	CcSEcCtD
Quetiapine—Confusional state—Fluorouracil—skin cancer	0.000241	0.000719	CcSEcCtD
Quetiapine—Pharyngitis—Docetaxel—skin cancer	0.000241	0.000719	CcSEcCtD
Quetiapine—Urinary tract disorder—Docetaxel—skin cancer	0.00024	0.000716	CcSEcCtD
Quetiapine—Oedema peripheral—Docetaxel—skin cancer	0.000239	0.000714	CcSEcCtD
Quetiapine—Anaphylactic shock—Fluorouracil—skin cancer	0.000239	0.000714	CcSEcCtD
Quetiapine—Connective tissue disorder—Docetaxel—skin cancer	0.000239	0.000712	CcSEcCtD
Quetiapine—Urethral disorder—Docetaxel—skin cancer	0.000238	0.000711	CcSEcCtD
Quetiapine—Infection—Fluorouracil—skin cancer	0.000237	0.000709	CcSEcCtD
Quetiapine—Feeling abnormal—Dactinomycin—skin cancer	0.000236	0.000706	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000236	0.000706	CcSEcCtD
Quetiapine—Insomnia—Temozolomide—skin cancer	0.000235	0.0007	CcSEcCtD
Quetiapine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000234	0.0007	CcSEcCtD
Quetiapine—Nervous system disorder—Fluorouracil—skin cancer	0.000234	0.0007	CcSEcCtD
Quetiapine—Thrombocytopenia—Fluorouracil—skin cancer	0.000234	0.000699	CcSEcCtD
Quetiapine—Visual impairment—Docetaxel—skin cancer	0.000234	0.000699	CcSEcCtD
Quetiapine—Tachycardia—Fluorouracil—skin cancer	0.000233	0.000696	CcSEcCtD
Quetiapine—Paraesthesia—Temozolomide—skin cancer	0.000233	0.000695	CcSEcCtD
Quetiapine—Dyspnoea—Temozolomide—skin cancer	0.000231	0.00069	CcSEcCtD
Quetiapine—Somnolence—Temozolomide—skin cancer	0.000231	0.000688	CcSEcCtD
Quetiapine—Erythema multiforme—Docetaxel—skin cancer	0.000229	0.000685	CcSEcCtD
Quetiapine—Dyspepsia—Temozolomide—skin cancer	0.000228	0.000682	CcSEcCtD
Quetiapine—Anorexia—Fluorouracil—skin cancer	0.000228	0.00068	CcSEcCtD
Quetiapine—Eye disorder—Docetaxel—skin cancer	0.000227	0.000677	CcSEcCtD
Quetiapine—Abdominal pain—Dactinomycin—skin cancer	0.000227	0.000677	CcSEcCtD
Quetiapine—Body temperature increased—Dactinomycin—skin cancer	0.000227	0.000677	CcSEcCtD
Quetiapine—Hypersensitivity—Bleomycin—skin cancer	0.000226	0.000676	CcSEcCtD
Quetiapine—Decreased appetite—Temozolomide—skin cancer	0.000225	0.000673	CcSEcCtD
Quetiapine—Cardiac disorder—Docetaxel—skin cancer	0.000225	0.000673	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000224	0.000669	CcSEcCtD
Quetiapine—Fatigue—Temozolomide—skin cancer	0.000224	0.000668	CcSEcCtD
Quetiapine—Hypotension—Fluorouracil—skin cancer	0.000223	0.000667	CcSEcCtD
Quetiapine—Constipation—Temozolomide—skin cancer	0.000222	0.000662	CcSEcCtD
Quetiapine—Pain—Temozolomide—skin cancer	0.000222	0.000662	CcSEcCtD
Quetiapine—Asthenia—Bleomycin—skin cancer	0.000221	0.000659	CcSEcCtD
Quetiapine—Angiopathy—Docetaxel—skin cancer	0.00022	0.000658	CcSEcCtD
Quetiapine—Immune system disorder—Docetaxel—skin cancer	0.000219	0.000655	CcSEcCtD
Quetiapine—Mediastinal disorder—Docetaxel—skin cancer	0.000219	0.000653	CcSEcCtD
Quetiapine—Chills—Docetaxel—skin cancer	0.000218	0.00065	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000218	0.00065	CcSEcCtD
Quetiapine—Pruritus—Bleomycin—skin cancer	0.000217	0.00065	CcSEcCtD
Quetiapine—Insomnia—Fluorouracil—skin cancer	0.000216	0.000645	CcSEcCtD
Quetiapine—Paraesthesia—Fluorouracil—skin cancer	0.000215	0.000641	CcSEcCtD
Quetiapine—Feeling abnormal—Temozolomide—skin cancer	0.000214	0.000638	CcSEcCtD
Quetiapine—Dyspnoea—Fluorouracil—skin cancer	0.000213	0.000636	CcSEcCtD
Quetiapine—Mental disorder—Docetaxel—skin cancer	0.000213	0.000635	CcSEcCtD
Quetiapine—Somnolence—Fluorouracil—skin cancer	0.000212	0.000634	CcSEcCtD
Quetiapine—Gastrointestinal pain—Temozolomide—skin cancer	0.000212	0.000633	CcSEcCtD
Quetiapine—Malnutrition—Docetaxel—skin cancer	0.000211	0.000631	CcSEcCtD
Quetiapine—Hypersensitivity—Dactinomycin—skin cancer	0.000211	0.000631	CcSEcCtD
Quetiapine—Dyspepsia—Fluorouracil—skin cancer	0.00021	0.000628	CcSEcCtD
Quetiapine—ABCB1—head—skin cancer	0.000209	0.00168	CbGeAlD
Quetiapine—Decreased appetite—Fluorouracil—skin cancer	0.000208	0.00062	CcSEcCtD
Quetiapine—Dysgeusia—Docetaxel—skin cancer	0.000207	0.000618	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000206	0.000616	CcSEcCtD
Quetiapine—Asthenia—Dactinomycin—skin cancer	0.000206	0.000614	CcSEcCtD
Quetiapine—Body temperature increased—Temozolomide—skin cancer	0.000205	0.000612	CcSEcCtD
Quetiapine—Abdominal pain—Temozolomide—skin cancer	0.000205	0.000612	CcSEcCtD
Quetiapine—Back pain—Docetaxel—skin cancer	0.000204	0.00061	CcSEcCtD
Quetiapine—Pain—Fluorouracil—skin cancer	0.000204	0.00061	CcSEcCtD
Quetiapine—Muscle spasms—Docetaxel—skin cancer	0.000203	0.000607	CcSEcCtD
Quetiapine—Feeling abnormal—Fluorouracil—skin cancer	0.000197	0.000588	CcSEcCtD
Quetiapine—Diarrhoea—Dactinomycin—skin cancer	0.000196	0.000586	CcSEcCtD
Quetiapine—Vomiting—Bleomycin—skin cancer	0.000195	0.000584	CcSEcCtD
Quetiapine—Anaemia—Docetaxel—skin cancer	0.000195	0.000583	CcSEcCtD
Quetiapine—Rash—Bleomycin—skin cancer	0.000194	0.000579	CcSEcCtD
Quetiapine—Dermatitis—Bleomycin—skin cancer	0.000194	0.000578	CcSEcCtD
Quetiapine—Hypersensitivity—Temozolomide—skin cancer	0.000191	0.000571	CcSEcCtD
Quetiapine—Syncope—Docetaxel—skin cancer	0.000189	0.000566	CcSEcCtD
Quetiapine—Leukopenia—Docetaxel—skin cancer	0.000189	0.000565	CcSEcCtD
Quetiapine—Body temperature increased—Fluorouracil—skin cancer	0.000189	0.000564	CcSEcCtD
Quetiapine—Palpitations—Docetaxel—skin cancer	0.000187	0.000558	CcSEcCtD
Quetiapine—Asthenia—Temozolomide—skin cancer	0.000186	0.000556	CcSEcCtD
Quetiapine—Loss of consciousness—Docetaxel—skin cancer	0.000186	0.000555	CcSEcCtD
Quetiapine—Cough—Docetaxel—skin cancer	0.000184	0.000551	CcSEcCtD
Quetiapine—Pruritus—Temozolomide—skin cancer	0.000183	0.000548	CcSEcCtD
Quetiapine—Convulsion—Docetaxel—skin cancer	0.000183	0.000547	CcSEcCtD
Quetiapine—Nausea—Bleomycin—skin cancer	0.000183	0.000545	CcSEcCtD
Quetiapine—Hypertension—Docetaxel—skin cancer	0.000182	0.000545	CcSEcCtD
Quetiapine—Vomiting—Dactinomycin—skin cancer	0.000182	0.000544	CcSEcCtD
Quetiapine—Rash—Dactinomycin—skin cancer	0.000181	0.00054	CcSEcCtD
Quetiapine—Arthralgia—Docetaxel—skin cancer	0.00018	0.000537	CcSEcCtD
Quetiapine—Chest pain—Docetaxel—skin cancer	0.00018	0.000537	CcSEcCtD
Quetiapine—Myalgia—Docetaxel—skin cancer	0.00018	0.000537	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000179	0.000534	CcSEcCtD
Quetiapine—Diarrhoea—Temozolomide—skin cancer	0.000177	0.00053	CcSEcCtD
Quetiapine—Hypersensitivity—Fluorouracil—skin cancer	0.000176	0.000526	CcSEcCtD
Quetiapine—Dry mouth—Docetaxel—skin cancer	0.000176	0.000525	CcSEcCtD
Quetiapine—Confusional state—Docetaxel—skin cancer	0.000174	0.000519	CcSEcCtD
Quetiapine—Anaphylactic shock—Docetaxel—skin cancer	0.000172	0.000515	CcSEcCtD
Quetiapine—Dizziness—Temozolomide—skin cancer	0.000171	0.000512	CcSEcCtD
Quetiapine—Infection—Docetaxel—skin cancer	0.000171	0.000512	CcSEcCtD
Quetiapine—Nausea—Dactinomycin—skin cancer	0.00017	0.000509	CcSEcCtD
Quetiapine—Shock—Docetaxel—skin cancer	0.00017	0.000507	CcSEcCtD
Quetiapine—Nervous system disorder—Docetaxel—skin cancer	0.000169	0.000505	CcSEcCtD
Quetiapine—Pruritus—Fluorouracil—skin cancer	0.000169	0.000505	CcSEcCtD
Quetiapine—Thrombocytopenia—Docetaxel—skin cancer	0.000169	0.000504	CcSEcCtD
Quetiapine—Tachycardia—Docetaxel—skin cancer	0.000168	0.000503	CcSEcCtD
Quetiapine—Skin disorder—Docetaxel—skin cancer	0.000167	0.0005	CcSEcCtD
Quetiapine—Vomiting—Temozolomide—skin cancer	0.000165	0.000492	CcSEcCtD
Quetiapine—Anorexia—Docetaxel—skin cancer	0.000164	0.000491	CcSEcCtD
Quetiapine—Rash—Temozolomide—skin cancer	0.000163	0.000488	CcSEcCtD
Quetiapine—Diarrhoea—Fluorouracil—skin cancer	0.000163	0.000488	CcSEcCtD
Quetiapine—Dermatitis—Temozolomide—skin cancer	0.000163	0.000488	CcSEcCtD
Quetiapine—Headache—Temozolomide—skin cancer	0.000162	0.000485	CcSEcCtD
Quetiapine—Hypotension—Docetaxel—skin cancer	0.000161	0.000481	CcSEcCtD
Quetiapine—Dizziness—Fluorouracil—skin cancer	0.000158	0.000472	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000157	0.000469	CcSEcCtD
Quetiapine—Insomnia—Docetaxel—skin cancer	0.000156	0.000466	CcSEcCtD
Quetiapine—Paraesthesia—Docetaxel—skin cancer	0.000155	0.000462	CcSEcCtD
Quetiapine—Nausea—Temozolomide—skin cancer	0.000154	0.00046	CcSEcCtD
Quetiapine—Dyspnoea—Docetaxel—skin cancer	0.000154	0.000459	CcSEcCtD
Quetiapine—Somnolence—Docetaxel—skin cancer	0.000153	0.000458	CcSEcCtD
Quetiapine—Vomiting—Fluorouracil—skin cancer	0.000152	0.000454	CcSEcCtD
Quetiapine—Dyspepsia—Docetaxel—skin cancer	0.000152	0.000453	CcSEcCtD
Quetiapine—Rash—Fluorouracil—skin cancer	0.000151	0.00045	CcSEcCtD
Quetiapine—Dermatitis—Fluorouracil—skin cancer	0.000151	0.000449	CcSEcCtD
Quetiapine—Decreased appetite—Docetaxel—skin cancer	0.00015	0.000448	CcSEcCtD
Quetiapine—Headache—Fluorouracil—skin cancer	0.00015	0.000447	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000149	0.000445	CcSEcCtD
Quetiapine—Fatigue—Docetaxel—skin cancer	0.000149	0.000444	CcSEcCtD
Quetiapine—Constipation—Docetaxel—skin cancer	0.000147	0.00044	CcSEcCtD
Quetiapine—Pain—Docetaxel—skin cancer	0.000147	0.00044	CcSEcCtD
Quetiapine—ABCB1—lymph node—skin cancer	0.000147	0.00118	CbGeAlD
Quetiapine—Feeling abnormal—Docetaxel—skin cancer	0.000142	0.000424	CcSEcCtD
Quetiapine—Nausea—Fluorouracil—skin cancer	0.000142	0.000424	CcSEcCtD
Quetiapine—Gastrointestinal pain—Docetaxel—skin cancer	0.000141	0.000421	CcSEcCtD
Quetiapine—Body temperature increased—Docetaxel—skin cancer	0.000136	0.000407	CcSEcCtD
Quetiapine—Abdominal pain—Docetaxel—skin cancer	0.000136	0.000407	CcSEcCtD
Quetiapine—Hypersensitivity—Docetaxel—skin cancer	0.000127	0.000379	CcSEcCtD
Quetiapine—Asthenia—Docetaxel—skin cancer	0.000124	0.00037	CcSEcCtD
Quetiapine—Pruritus—Docetaxel—skin cancer	0.000122	0.000364	CcSEcCtD
Quetiapine—Diarrhoea—Docetaxel—skin cancer	0.000118	0.000352	CcSEcCtD
Quetiapine—Dizziness—Docetaxel—skin cancer	0.000114	0.000341	CcSEcCtD
Quetiapine—Vomiting—Docetaxel—skin cancer	0.00011	0.000327	CcSEcCtD
Quetiapine—Rash—Docetaxel—skin cancer	0.000109	0.000325	CcSEcCtD
Quetiapine—Dermatitis—Docetaxel—skin cancer	0.000109	0.000324	CcSEcCtD
Quetiapine—Headache—Docetaxel—skin cancer	0.000108	0.000323	CcSEcCtD
Quetiapine—Nausea—Docetaxel—skin cancer	0.000102	0.000306	CcSEcCtD
Quetiapine—ADRA2C—Signaling Pathways—TERT—skin cancer	1.25e-05	0.000175	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—NRAS—skin cancer	1.25e-05	0.000175	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—NRAS—skin cancer	1.25e-05	0.000175	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—BRAF—skin cancer	1.25e-05	0.000175	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.24e-05	0.000173	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TERT—skin cancer	1.23e-05	0.000172	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—KRAS—skin cancer	1.23e-05	0.000172	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—KRAS—skin cancer	1.21e-05	0.00017	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—KRAS—skin cancer	1.2e-05	0.000167	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—BRAF—skin cancer	1.19e-05	0.000167	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ERCC2—skin cancer	1.19e-05	0.000166	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—BRAF—skin cancer	1.18e-05	0.000164	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—BRAF—skin cancer	1.18e-05	0.000164	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—KRAS—skin cancer	1.15e-05	0.00016	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—TP53—skin cancer	1.14e-05	0.00016	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TERT—skin cancer	1.14e-05	0.000159	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—NRAS—skin cancer	1.13e-05	0.000158	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—NRAS—skin cancer	1.13e-05	0.000158	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TERT—skin cancer	1.12e-05	0.000156	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TERT—skin cancer	1.12e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000155	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TERT—skin cancer	1.1e-05	0.000154	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—KRAS—skin cancer	1.1e-05	0.000153	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TERT—skin cancer	1.1e-05	0.000153	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—HRAS—skin cancer	1.09e-05	0.000153	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—KRAS—skin cancer	1.09e-05	0.000153	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—NRAS—skin cancer	1.09e-05	0.000153	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—NRAS—skin cancer	1.09e-05	0.000152	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—HRAS—skin cancer	1.08e-05	0.000151	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—KRAS—skin cancer	1.08e-05	0.000151	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—KRAS—skin cancer	1.08e-05	0.000151	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—HRAS—skin cancer	1.08e-05	0.000151	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—HRAS—skin cancer	1.07e-05	0.00015	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—BRAF—skin cancer	1.06e-05	0.000148	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—NRAS—skin cancer	1.06e-05	0.000148	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—HRAS—skin cancer	1.05e-05	0.000146	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—NRAS—skin cancer	1.04e-05	0.000145	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—IL6—skin cancer	1.03e-05	0.000144	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—HRAS—skin cancer	1.03e-05	0.000144	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—IL6—skin cancer	1.03e-05	0.000144	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—BRAF—skin cancer	1.03e-05	0.000143	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—IL6—skin cancer	1.03e-05	0.000143	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—BRAF—skin cancer	1.02e-05	0.000143	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TERT—skin cancer	1.02e-05	0.000142	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—HRAS—skin cancer	1.02e-05	0.000142	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—IL6—skin cancer	1e-05	0.00014	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—BRAF—skin cancer	9.93e-06	0.000139	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PTGS2—skin cancer	9.88e-06	0.000138	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—IL6—skin cancer	9.88e-06	0.000138	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—BRAF—skin cancer	9.77e-06	0.000137	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—skin cancer	9.76e-06	0.000136	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—HRAS—skin cancer	9.75e-06	0.000136	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—IL6—skin cancer	9.74e-06	0.000136	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—KRAS—skin cancer	9.74e-06	0.000136	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—KRAS—skin cancer	9.72e-06	0.000136	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PTGS2—skin cancer	9.59e-06	0.000134	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—NRAS—skin cancer	9.59e-06	0.000134	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ENO2—skin cancer	9.53e-06	0.000133	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—NRAS—skin cancer	9.43e-06	0.000132	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—NRAS—skin cancer	9.41e-06	0.000131	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—KRAS—skin cancer	9.4e-06	0.000131	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—NRAS—skin cancer	9.38e-06	0.000131	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—NRAS—skin cancer	9.35e-06	0.000131	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—KRAS—skin cancer	9.35e-06	0.000131	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—HRAS—skin cancer	9.33e-06	0.00013	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—IL6—skin cancer	9.33e-06	0.00013	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—HRAS—skin cancer	9.29e-06	0.00013	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—NRAS—skin cancer	9.26e-06	0.000129	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	9.24e-06	0.000129	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ERCC2—skin cancer	9.21e-06	0.000129	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—HRAS—skin cancer	9.17e-06	0.000128	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—HRAS—skin cancer	9.17e-06	0.000128	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—KRAS—skin cancer	9.09e-06	0.000127	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—BRAF—skin cancer	9.01e-06	0.000126	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ERCC2—skin cancer	8.99e-06	0.000126	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—KRAS—skin cancer	8.95e-06	0.000125	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL6—skin cancer	8.93e-06	0.000125	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL6—skin cancer	8.89e-06	0.000124	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—BRAF—skin cancer	8.87e-06	0.000124	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—BRAF—skin cancer	8.85e-06	0.000124	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—BRAF—skin cancer	8.82e-06	0.000123	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—BRAF—skin cancer	8.79e-06	0.000123	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL6—skin cancer	8.77e-06	0.000123	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL6—skin cancer	8.77e-06	0.000123	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—NRAS—skin cancer	8.71e-06	0.000122	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—BRAF—skin cancer	8.71e-06	0.000122	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—NRAS—skin cancer	8.7e-06	0.000122	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—BRAF—skin cancer	8.68e-06	0.000121	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—NRAS—skin cancer	8.65e-06	0.000121	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—skin cancer	8.64e-06	0.000121	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	8.58e-06	0.00012	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—skin cancer	8.49e-06	0.000119	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ERCC2—skin cancer	8.47e-06	0.000118	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—NRAS—skin cancer	8.47e-06	0.000118	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—NRAS—skin cancer	8.33e-06	0.000116	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—HRAS—skin cancer	8.28e-06	0.000116	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—HRAS—skin cancer	8.26e-06	0.000115	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—KRAS—skin cancer	8.25e-06	0.000115	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—NRAS—skin cancer	8.22e-06	0.000115	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—KRAS—skin cancer	8.12e-06	0.000113	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—KRAS—skin cancer	8.1e-06	0.000113	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—KRAS—skin cancer	8.08e-06	0.000113	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—BRAF—skin cancer	8.07e-06	0.000113	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—KRAS—skin cancer	8.05e-06	0.000112	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—HRAS—skin cancer	7.99e-06	0.000112	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—KRAS—skin cancer	7.97e-06	0.000111	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	7.95e-06	0.000111	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—HRAS—skin cancer	7.95e-06	0.000111	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL6—skin cancer	7.92e-06	0.000111	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL6—skin cancer	7.91e-06	0.00011	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—NRAS—skin cancer	7.87e-06	0.00011	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—skin cancer	7.79e-06	0.000109	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—HRAS—skin cancer	7.73e-06	0.000108	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—skin cancer	7.65e-06	0.000107	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—HRAS—skin cancer	7.61e-06	0.000106	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—skin cancer	7.61e-06	0.000106	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—NRAS—skin cancer	7.5e-06	0.000105	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—KRAS—skin cancer	7.5e-06	0.000105	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—KRAS—skin cancer	7.49e-06	0.000105	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—KRAS—skin cancer	7.44e-06	0.000104	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—NRAS—skin cancer	7.4e-06	0.000103	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—NRAS—skin cancer	7.4e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—skin cancer	7.4e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	7.39e-06	0.000103	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—KRAS—skin cancer	7.29e-06	0.000102	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—skin cancer	7.28e-06	0.000102	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KRAS—skin cancer	7.17e-06	0.0001	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—skin cancer	7.14e-06	9.97e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KRAS—skin cancer	7.08e-06	9.88e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—HRAS—skin cancer	7.01e-06	9.8e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—HRAS—skin cancer	6.9e-06	9.64e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—HRAS—skin cancer	6.89e-06	9.62e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—HRAS—skin cancer	6.86e-06	9.59e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—HRAS—skin cancer	6.84e-06	9.56e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—HRAS—skin cancer	6.78e-06	9.46e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KRAS—skin cancer	6.78e-06	9.46e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	6.76e-06	9.44e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—skin cancer	6.71e-06	9.38e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NRAS—skin cancer	6.68e-06	9.33e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—skin cancer	6.67e-06	9.31e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—skin cancer	6.66e-06	9.3e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—skin cancer	6.62e-06	9.24e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—skin cancer	6.61e-06	9.22e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—skin cancer	6.59e-06	9.2e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—skin cancer	6.57e-06	9.18e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—skin cancer	6.55e-06	9.15e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—skin cancer	6.49e-06	9.06e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—skin cancer	6.48e-06	9.05e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—skin cancer	6.47e-06	9.03e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KRAS—skin cancer	6.46e-06	9.02e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NRAS—skin cancer	6.45e-06	9.01e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NRAS—skin cancer	6.42e-06	8.96e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HRAS—skin cancer	6.38e-06	8.9e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—skin cancer	6.37e-06	8.9e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KRAS—skin cancer	6.37e-06	8.9e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KRAS—skin cancer	6.37e-06	8.9e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HRAS—skin cancer	6.37e-06	8.89e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HRAS—skin cancer	6.33e-06	8.84e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—skin cancer	6.29e-06	8.78e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	6.28e-06	8.77e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NRAS—skin cancer	6.24e-06	8.72e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HRAS—skin cancer	6.19e-06	8.65e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NRAS—skin cancer	6.14e-06	8.58e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—skin cancer	6.1e-06	8.52e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—skin cancer	6.1e-06	8.51e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—skin cancer	6.1e-06	8.51e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—skin cancer	6.06e-06	8.46e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—skin cancer	6.02e-06	8.41e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—skin cancer	6.01e-06	8.4e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—skin cancer	6.01e-06	8.39e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—skin cancer	5.93e-06	8.28e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—skin cancer	5.83e-06	8.15e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—skin cancer	5.76e-06	8.04e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—skin cancer	5.76e-06	8.04e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—skin cancer	5.75e-06	8.03e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—skin cancer	5.74e-06	8.01e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NRAS—skin cancer	5.66e-06	7.91e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—skin cancer	5.66e-06	7.91e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—skin cancer	5.66e-06	7.91e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NRAS—skin cancer	5.57e-06	7.78e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NRAS—skin cancer	5.56e-06	7.77e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—skin cancer	5.55e-06	7.75e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NRAS—skin cancer	5.54e-06	7.74e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ERCC2—skin cancer	5.54e-06	7.73e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NRAS—skin cancer	5.53e-06	7.72e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—skin cancer	5.52e-06	7.71e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—skin cancer	5.52e-06	7.71e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—skin cancer	5.51e-06	7.7e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—skin cancer	5.49e-06	7.66e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NRAS—skin cancer	5.47e-06	7.64e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NRAS—skin cancer	5.46e-06	7.62e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—skin cancer	5.41e-06	7.56e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—skin cancer	5.41e-06	7.56e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—skin cancer	5.39e-06	7.53e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—skin cancer	5.37e-06	7.5e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—skin cancer	5.29e-06	7.38e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—skin cancer	5.25e-06	7.34e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—skin cancer	5.18e-06	7.24e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—skin cancer	5.18e-06	7.24e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—skin cancer	5.11e-06	7.14e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—skin cancer	5.08e-06	7.09e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NRAS—skin cancer	5.07e-06	7.08e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—skin cancer	4.93e-06	6.89e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—skin cancer	4.91e-06	6.86e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—skin cancer	4.89e-06	6.83e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—skin cancer	4.87e-06	6.81e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—skin cancer	4.8e-06	6.7e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—skin cancer	4.79e-06	6.68e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—skin cancer	4.77e-06	6.67e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—skin cancer	4.77e-06	6.66e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—skin cancer	4.76e-06	6.64e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—skin cancer	4.72e-06	6.59e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—skin cancer	4.71e-06	6.58e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—skin cancer	4.7e-06	6.56e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—skin cancer	4.7e-06	6.56e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—skin cancer	4.69e-06	6.56e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—skin cancer	4.68e-06	6.53e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—skin cancer	4.57e-06	6.38e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—skin cancer	4.52e-06	6.31e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—skin cancer	4.49e-06	6.28e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—skin cancer	4.49e-06	6.28e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—skin cancer	4.37e-06	6.1e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—skin cancer	4.36e-06	6.09e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—skin cancer	4.33e-06	6.05e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—skin cancer	4.3e-06	6.01e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—skin cancer	4.26e-06	5.95e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—skin cancer	4.25e-06	5.94e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—skin cancer	4.24e-06	5.92e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—skin cancer	4.23e-06	5.9e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—skin cancer	4.19e-06	5.85e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—skin cancer	4.17e-06	5.83e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—skin cancer	4.14e-06	5.79e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—skin cancer	4.08e-06	5.69e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—skin cancer	4.07e-06	5.68e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—skin cancer	4.06e-06	5.66e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—skin cancer	4.04e-06	5.65e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—skin cancer	4e-06	5.59e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—skin cancer	3.99e-06	5.58e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—skin cancer	3.97e-06	5.54e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—skin cancer	3.9e-06	5.45e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—skin cancer	3.89e-06	5.44e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—skin cancer	3.88e-06	5.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—skin cancer	3.88e-06	5.42e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—skin cancer	3.87e-06	5.4e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—skin cancer	3.83e-06	5.35e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—skin cancer	3.82e-06	5.34e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—skin cancer	3.71e-06	5.18e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—skin cancer	3.55e-06	4.96e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—skin cancer	3.32e-06	4.64e-05	CbGpPWpGaD
